Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 81Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Arevipharma GmbH

02 1Medisca Inc.

03 1Olon SpA

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

DIETHYLPROPION HYDROCHLORIDE

NDC Package Code : 38779-0926

Start Marketing Date : 2014-08-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

Looking for 134-80-5 / Diethylpropion Hydrochloride API manufacturers, exporters & distributors?

Diethylpropion Hydrochloride manufacturers, exporters & distributors 1

66

PharmaCompass offers a list of Diethylpropion Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier.

PharmaCompass also assists you with knowing the Diethylpropion Hydrochloride API Price utilized in the formulation of products. Diethylpropion Hydrochloride API Price is not always fixed or binding as the Diethylpropion Hydrochloride Price is obtained through a variety of data sources. The Diethylpropion Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Diethylpropion Hydrochloride

Synonyms

Amfepramone hydrochloride, 134-80-5, Moderatan, Dobesin, Tenuate, Diethylpropion hcl

Cas Number

134-80-5

Unique Ingredient Identifier (UNII)

19V2PL39NG

About Diethylpropion Hydrochloride

A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)

Magrex Retard Manufacturers

A Magrex Retard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magrex Retard, including repackagers and relabelers. The FDA regulates Magrex Retard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magrex Retard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Magrex Retard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Magrex Retard Suppliers

A Magrex Retard supplier is an individual or a company that provides Magrex Retard active pharmaceutical ingredient (API) or Magrex Retard finished formulations upon request. The Magrex Retard suppliers may include Magrex Retard API manufacturers, exporters, distributors and traders.

click here to find a list of Magrex Retard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Magrex Retard NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Magrex Retard as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Magrex Retard API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Magrex Retard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Magrex Retard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Magrex Retard NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Magrex Retard suppliers with NDC on PharmaCompass.

Magrex Retard Manufacturers | Traders | Suppliers

Magrex Retard Manufacturers, Traders, Suppliers 1
70

We have 3 companies offering Magrex Retard

Get in contact with the supplier of your choice:

  1. Arevipharma
  2. Medisca
  3. Olon S.p.A
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.